https://www.prescriptionanalytics.com/white-paper/medicaid-from-a-simple-concept-to-an-operational-labyrinth/attachment/inflation-act/ 2022-11-18T16:18:47+00:00 https://www.prescriptionanalytics.com/white-paper/medicaid-from-a-simple-concept-to-an-operational-labyrinth/attachment/medacaid-hero-image-1920/ 2022-11-18T16:18:49+00:00 https://www.prescriptionanalytics.com/white-paper/key-terms-in-pharmaceutical-government-pricing/attachment/key-pharmaceutical-pricing-terms/ 2022-11-18T16:20:44+00:00 https://www.prescriptionanalytics.com/white-paper/unit-rebate-amount-calculation-for-medicaid/attachment/unit-rebate-amount-calculation-for-medicaid-1700a/ 2022-12-05T12:28:19+00:00 https://www.prescriptionanalytics.com/white-paper/unit-rebate-amount-calculation-for-medicaid/attachment/unit-rebate-amount-calculation-for-medicaid-1700-featured-image/ 2022-12-05T12:31:25+00:00 https://www.prescriptionanalytics.com/white-paper/drug-price-disclosure-legislation-april-2019/attachment/drug-price-disclosure-legislation-1200x370-1-featured-image/ 2022-12-05T20:51:23+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation-april-2020/attachment/drug-price-disclosure-featured-image/ 2022-12-06T18:54:46+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation/attachment/legislation-1200x250-1-featured-image/ 2022-12-06T19:57:17+00:00 https://www.prescriptionanalytics.com/white-paper/avoiding-costly-government-pricing-mistakes/attachment/pricing-mistakes-1200x600-1-featured-image/ 2022-12-07T14:20:41+00:00 https://www.prescriptionanalytics.com/white-paper/baseline-amp/attachment/understanding-baseline-amp-featured-image/ 2022-12-07T19:17:34+00:00 https://www.prescriptionanalytics.com/white-paper/key-terms-in-pharmaceutical-government-pricing/attachment/key-pharma-pricing-terms-feature-image-400x207/ 2022-12-07T19:31:08+00:00 https://www.prescriptionanalytics.com/white-paper/drug-price-disclosure-legislation-april-2019/attachment/drug-price-disclosure-legislation-1200x600-1-400x200/ 2022-12-07T19:39:40+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation-april-2020/attachment/legislation-1200x600-1-400x200/ 2022-12-07T19:41:55+00:00 https://www.prescriptionanalytics.com/white-paper/baseline-amp/attachment/amp-thumbnail-1200x620-01-400x206/ 2022-12-07T19:48:26+00:00 https://www.prescriptionanalytics.com/white-paper/unit-rebate-amount-calculation-for-medicaid/attachment/unit-rebate-amount-calculation-for-medicaid-1200x630-1-400x202/ 2022-12-07T19:50:41+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation/attachment/usd-dollar-bills-in-a-drug-bottle-over-the-medical-pills-medici-2/ 2022-12-07T19:52:14+00:00 https://www.prescriptionanalytics.com/white-paper/avoiding-costly-government-pricing-mistakes/attachment/pricing-mistakes-1200x600-1-400x200/ 2022-12-07T19:55:49+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation/attachment/legislation-1200x600-1-400x200-2/ 2022-12-07T20:47:33+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation-april-2020/attachment/usd-dollar-bills-in-a-drug-bottle-over-the-medical-pills-medici-4/ 2022-12-07T20:52:08+00:00 https://www.prescriptionanalytics.com/white-paper/baseline-amp/attachment/amp-thumbnail-1200x620-01-400x200-featured-image/ 2022-12-08T14:24:25+00:00 https://www.prescriptionanalytics.com/blog/why-medicaid-is-a-pharma-companys-most-demanding-government-program-in-terms-of-potential-impact-and-resources/attachment/medicaid-400x200/ 2022-12-08T14:36:34+00:00 https://www.prescriptionanalytics.com/blog/have-confidence-in-the-data-that-drives-government-pricing-computations/attachment/confidence-in-the-data-that-drives-government-pricing-computations/ 2022-12-08T14:47:40+00:00 https://www.prescriptionanalytics.com/blog/have-confidence-in-the-data-that-drives-government-pricing-computations/attachment/confidence-in-the-data-featured-image/ 2022-12-08T14:50:54+00:00 https://www.prescriptionanalytics.com/blog/understanding-the-complexities-of-implementing-a-generic-pharmaceutical-company-commercialization-plan/attachment/salesoperationsupportblog-1200x630a-400x200/ 2022-12-08T14:57:48+00:00 https://www.prescriptionanalytics.com/blog/system-based-calculations-miss-crucial-details-in-government-pricing-reports/attachment/system-based-calculations-400x200/ 2022-12-08T15:03:12+00:00 https://www.prescriptionanalytics.com/blog/have-you-been-lulled-into-complacency-by-a-system-based-government-pricing-solution/attachment/lulled-into-complacency-feature-image-400x200/ 2022-12-08T15:11:13+00:00 https://www.prescriptionanalytics.com/blog/mergers-and-acquisitions-never-end-in-a-tie/attachment/blog-mergers-integrichain_1200x600-400x200/ 2022-12-08T16:31:06+00:00 https://www.prescriptionanalytics.com/white-paper/another-update-on-drug-price-disclosure-legislation/attachment/drugpricedisclosurelegislation-1200x620-1-400x207/ 2022-12-08T16:36:39+00:00 https://www.prescriptionanalytics.com/white-paper/another-update-on-drug-price-disclosure-legislation/attachment/drugpricedisclosurelegislation-1200x620-1-400x200/ 2022-12-08T16:42:15+00:00 https://www.prescriptionanalytics.com/white-paper/factors-to-consider-when-acquiring-and-launching/attachment/factors-to-consider-prescription-analytics-1200x600-1-400x200/ 2022-12-08T18:44:34+00:00 https://www.prescriptionanalytics.com/blog/three-things-to-know-about-the-challenges-of-va-fss-contracting/attachment/va_blogheader-web-1200x600-1-400x200/ 2022-12-08T19:00:33+00:00 https://www.prescriptionanalytics.com/blog/american-rescue-plan-act-of-2021/attachment/arpa-blogheader-feature-1200x620-1-400x200/ 2022-12-08T19:20:07+00:00 https://www.prescriptionanalytics.com/blog/letting-some-air-out-of-the-amp-inflation-penalty/attachment/inflationheader-thumbnail-01-400x200/ 2022-12-08T19:36:30+00:00 https://www.prescriptionanalytics.com/blog/reasons-brand-drug-manufacturers-must-prepare-for-final-rule-changes/attachment/changes-ahead-1200x630-1-400x200/ 2022-12-08T19:59:09+00:00 https://www.prescriptionanalytics.com/white-paper/phs-340b-audit-survival-guide/attachment/audit-survival-guide-1200x600-1-400x200/ 2022-12-09T18:17:39+00:00 https://www.prescriptionanalytics.com/blog/is-wholesale-distribution-the-best-option-for-drug-manufacturers/attachment/xxx-pharmaceuticals-1-400x200/ 2022-12-12T18:53:28+00:00 https://www.prescriptionanalytics.com/white-paper/why-have-my-medicaid-rebate-payments-and-processing-load-seen-such-a-sharp-increase/attachment/effects-of-medicaidenrollment-feature-image-400x200/ 2022-12-12T19:34:21+00:00 https://www.prescriptionanalytics.com/blog/reasons-to-prepare-now-for-the-2024-medicaid-rebate-cap-removal/attachment/blog-12-feature-image-web-400x200/ 2022-12-12T20:10:10+00:00 https://www.prescriptionanalytics.com/blog/update-2023-best-price-accumulator-adjustment-program-ruling/attachment/2023_best_price_accumulator_adjustment_program_ruling-featured-image/ 2022-12-13T12:49:21+00:00 https://www.prescriptionanalytics.com/blog/part-i-unwinding-medicaid-continuous-enrollment/attachment/blog16-headerimage-1200x630-1-400x200/ 2022-12-13T14:41:32+00:00 https://www.prescriptionanalytics.com/blog/branded-prescription-drug-fee-payment-deadline-approaching/attachment/brandtax-headerimage-1200x630-feature-image-400x200/ 2022-12-13T15:23:33+00:00 https://www.prescriptionanalytics.com/white-paper/beware-of-the-many-operational-challenges-of-medicaid-rebate-processing/attachment/whitepaper10_coverimage-thumbnail-400x200/ 2022-12-13T15:42:56+00:00 https://www.prescriptionanalytics.com/blog/inflation-reduction-act-likely-to-have-a-negative-financial-impact-on-many-drug-manufacturers/attachment/inflation-act-1200x630-1-400x200-featured-image/ 2022-12-13T16:40:12+00:00 https://www.prescriptionanalytics.com/white-paper/understanding-class-of-trade-cot-in-the-pharmaceutical-industry/attachment/class-of-trade-1200x630-1-400x200/ 2022-12-13T18:58:09+00:00 https://www.prescriptionanalytics.com/pricing/2020-budgeting/attachment/pricing-1200x600-1-400x200/ 2022-12-13T19:23:43+00:00 https://www.prescriptionanalytics.com/white-paper/key-terms-in-pharmaceutical-government-pricing/attachment/key-pharma-pricing-terms-feature-image-resized-400x200/ 2022-12-14T12:10:04+00:00 https://www.prescriptionanalytics.com/white-paper/top-3-reasons-your-amp-changed/attachment/top-3-reasons-your-amp-changed-2/ 2023-01-23T16:53:54+00:00 https://www.prescriptionanalytics.com/white-paper/top-3-reasons-your-amp-changed/attachment/top-3-reasons-your-amp-changed-feature-image-400x210/ 2023-01-23T16:54:43+00:00 https://www.prescriptionanalytics.com/white-paper/top-3-reasons-your-amp-changed/attachment/bob-devenport-200x200/ 2023-01-23T17:02:18+00:00 https://www.prescriptionanalytics.com/white-paper/medicaid-from-a-simple-concept-to-an-operational-labyrinth/attachment/medacaid-image-1/ 2023-01-30T21:10:42+00:00 https://www.prescriptionanalytics.com/white-paper/top-3-reasons-your-amp-changed/attachment/top-3-reasons-your-amp-changed-f1-image/ 2023-01-30T21:13:18+00:00 https://www.prescriptionanalytics.com/white-paper/medicaid-from-a-simple-concept-to-an-operational-labyrinth/attachment/medacaid-featured-image/ 2023-02-01T20:06:11+00:00 https://www.prescriptionanalytics.com/blog/inflation-reduction-act-likely-to-have-a-negative-financial-impact-on-many-drug-manufacturers/attachment/inflation-act-featured-1-1/ 2023-02-01T20:11:53+00:00 https://www.prescriptionanalytics.com/blog/inflation-reduction-act-likely-to-have-a-negative-financial-impact-on-many-drug-manufacturers/attachment/inflation-act-featured-2-2/ 2023-02-01T20:21:16+00:00 https://www.prescriptionanalytics.com/blog/inflation-reduction-act-likely-to-have-a-negative-financial-impact-on-many-drug-manufacturers/attachment/inflation-act-1200x630-1-600x315/ 2023-02-01T20:32:28+00:00 https://www.prescriptionanalytics.com/blog/inflation-reduction-act-likely-to-have-a-negative-financial-impact-on-many-drug-manufacturers/attachment/inflation-act-featured/ 2023-02-01T20:35:43+00:00 https://www.prescriptionanalytics.com/white-paper/top-3-reasons-your-amp-changed/attachment/top-3-reasons-your-amp-changed-f/ 2023-02-01T22:00:31+00:00 https://www.prescriptionanalytics.com/blog/inflation-reduction-act-likely-to-have-a-negative-financial-impact-on-many-drug-manufacturers/attachment/inflation-act-r-featured/ 2023-02-02T14:24:45+00:00 https://www.prescriptionanalytics.com/white-paper/medicaid-from-a-simple-concept-to-an-operational-labyrinth/attachment/medacaid-r-featured-image/ 2023-02-02T14:28:25+00:00 https://www.prescriptionanalytics.com/white-paper/understanding-class-of-trade-cot-in-the-pharmaceutical-industry/attachment/class-of-trade-featured/ 2023-02-02T14:36:00+00:00 https://www.prescriptionanalytics.com/white-paper/unit-rebate-amount-calculation-for-medicaid/attachment/unit-rebate-amount-calculation-for-medicaid-featured/ 2023-02-02T14:41:39+00:00 https://www.prescriptionanalytics.com/white-paper/beware-of-the-many-operational-challenges-of-medicaid-rebate-processing/attachment/whitepaper10_coverimage-featured/ 2023-02-02T14:47:24+00:00 https://www.prescriptionanalytics.com/blog/branded-prescription-drug-fee-payment-deadline-approaching/attachment/brandtax-headerimage-feature/ 2023-02-02T14:57:38+00:00 https://www.prescriptionanalytics.com/white-paper/key-terms-in-pharmaceutical-government-pricing/attachment/key-pharma-pricing-terms-feature/ 2023-02-02T15:04:29+00:00 https://www.prescriptionanalytics.com/blog/part-i-unwinding-medicaid-continuous-enrollment/attachment/blog16-feature/ 2023-02-02T15:07:13+00:00 https://www.prescriptionanalytics.com/blog/update-2023-best-price-accumulator-adjustment-program-ruling/attachment/2023_best_price_accumulator_adjustment_program_ruling-featured/ 2023-02-02T15:09:46+00:00 https://www.prescriptionanalytics.com/blog/reasons-to-prepare-now-for-the-2024-medicaid-rebate-cap-removal/attachment/reasons-to-prepare-now-for-the-2024-medicaid-rebate-cap-removal-featured/ 2023-02-02T18:38:41+00:00 https://www.prescriptionanalytics.com/white-paper/why-have-my-medicaid-rebate-payments-and-processing-load-seen-such-a-sharp-increase/attachment/effects-of-medicaidenrollment-feature/ 2023-02-02T18:42:57+00:00 https://www.prescriptionanalytics.com/blog/is-wholesale-distribution-the-best-option-for-drug-manufacturers/attachment/xxx-pharmaceuticals-featured/ 2023-02-02T18:46:03+00:00 https://www.prescriptionanalytics.com/white-paper/phs-340b-audit-survival-guide/attachment/audit-survival-guide-featured/ 2023-02-02T19:08:58+00:00 https://www.prescriptionanalytics.com/white-paper/phs-340b-audit-survival-guide/attachment/audit-survival-guide-featured-2/ 2023-02-02T19:11:14+00:00 https://www.prescriptionanalytics.com/blog/reasons-brand-drug-manufacturers-must-prepare-for-final-rule-changes/attachment/changes-ahead-featured-3/ 2023-02-02T19:15:53+00:00 https://www.prescriptionanalytics.com/blog/letting-some-air-out-of-the-amp-inflation-penalty/attachment/inflationheader-featured/ 2023-02-02T19:19:39+00:00 https://www.prescriptionanalytics.com/blog/american-rescue-plan-act-of-2021/attachment/arpa-blogheader-feature/ 2023-02-02T19:22:52+00:00 https://www.prescriptionanalytics.com/blog/three-things-to-know-about-the-challenges-of-va-fss-contracting/attachment/va_blogheader-web-featured/ 2023-02-02T19:25:08+00:00 https://www.prescriptionanalytics.com/white-paper/factors-to-consider-when-acquiring-and-launching/attachment/factors-to-consider-prescription-analytics-featured/ 2023-02-02T19:55:02+00:00 https://www.prescriptionanalytics.com/white-paper/another-update-on-drug-price-disclosure-legislation/attachment/drugpricedisclosurelegislation-featured/ 2023-02-02T20:50:50+00:00 https://www.prescriptionanalytics.com/blog/mergers-and-acquisitions-never-end-in-a-tie/attachment/blog-mergers-integrichain_featured/ 2023-02-02T20:54:23+00:00 https://www.prescriptionanalytics.com/blog/have-you-been-lulled-into-complacency-by-a-system-based-government-pricing-solution/attachment/post-1155206040-01-feature/ 2023-02-02T21:00:01+00:00 https://www.prescriptionanalytics.com/blog/system-based-calculations-miss-crucial-details-in-government-pricing-reports/attachment/system-based-calculations-featured/ 2023-02-02T21:04:44+00:00 https://www.prescriptionanalytics.com/blog/have-confidence-in-the-data-that-drives-government-pricing-computations/attachment/confidence-in-the-data-that-drives-government-pricing-computations-feature/ 2023-02-02T21:06:33+00:00 https://www.prescriptionanalytics.com/blog/why-medicaid-is-a-pharma-companys-most-demanding-government-program-in-terms-of-potential-impact-and-resources/attachment/medicaid-featured/ 2023-02-02T21:10:21+00:00 https://www.prescriptionanalytics.com/blog/understanding-the-complexities-of-implementing-a-generic-pharmaceutical-company-commercialization-plan/attachment/698595908_salesoperationsupportblog-featured/ 2023-02-02T21:32:00+00:00 https://www.prescriptionanalytics.com/white-paper/baseline-amp/attachment/amp-thumbnail-feature/ 2023-02-02T21:34:42+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation-april-2020/attachment/drug_price_transparency_laws_featured/ 2023-02-03T14:13:59+00:00 https://www.prescriptionanalytics.com/white-paper/avoiding-costly-government-pricing-mistakes/attachment/pricing-mistakes-featured/ 2023-02-03T14:16:07+00:00 https://www.prescriptionanalytics.com/white-paper/continued-emergence-of-drug-price-disclosure-legislation/attachment/legislation-featured/ 2023-02-03T14:18:08+00:00 https://www.prescriptionanalytics.com/white-paper/drug-price-disclosure-legislation-april-2019/attachment/drug-price-disclosure-legislation-featured/ 2023-02-03T14:33:55+00:00 https://www.prescriptionanalytics.com/blog/cms-enforcement-for-asp-in-medicare-part-b/attachment/cms-enforcement-for-asp-in-medicare-part-b-header/ 2023-02-20T16:10:08+00:00 https://www.prescriptionanalytics.com/blog/cms-enforcement-for-asp-in-medicare-part-b/attachment/cms-enforcement-for-asp-in-medicare-part-b-2/ 2023-02-20T19:17:56+00:00 https://www.prescriptionanalytics.com/blog/inflation-reduction-act/attachment/pai-blog-ira-feature-image-400x210/ 2023-03-07T18:22:52+00:00 https://www.prescriptionanalytics.com/blog/medicaid-rebate-liability-forecasting-after-unwinding-puerto-rico-inclusion/attachment/blog19_feat-image-resized/ 2023-04-19T14:00:22+00:00 https://www.prescriptionanalytics.com/white-paper/chargeback-processing-best-practices-to-avoid-revenue-leakage-risk/attachment/may-23-23-blog-feat-image/ 2023-05-23T10:34:59+00:00 https://www.prescriptionanalytics.com/blog/the-2024-medicaid-amp-cap-removal-what-pharma-manufacturers-need-to-know/attachment/8-2023-blog-feat-image-resized-2/ 2023-08-17T15:46:49+00:00 https://www.prescriptionanalytics.com/white-paper/mastering-best-practices-vetting-previously-marketed-pharmaceutical-drug-acquisitions/attachment/featuredimage-pharmaceutical-drug-acquisition-best-practices-white-paper/ 2023-09-15T11:36:23+00:00 https://www.prescriptionanalytics.com/blog/understanding-the-medicare-phase-in-what-it-means-to-qualify-as-a-specified-manufacturer/attachment/thumbnailimage_med-d-blog-feat-image-resized/ 2024-02-06T17:18:09+00:00 https://www.prescriptionanalytics.com/white-paper/navigating-the-texas-medicaid-formulary-a-comprehensive-guide-for-pharmaceutical-manufacturers/attachment/thumbnailimage_txmedicaidformulary-blog-feat-image-resized/ 2024-02-26T12:15:55+00:00 https://www.prescriptionanalytics.com/blog/navigating-change-a-deep-dive-into-the-pending-cms-rule-cms-2434-for-pharma-manufacturers/attachment/thumbnailimage_cmspendingfinalrule-blog-feat-image/ 2024-04-26T12:55:47+00:00 https://www.prescriptionanalytics.com/white-paper/understanding-prescription-drug-line-extensions-key-insights-on-ura-medicaid-rebates-and-340b-program-impact/attachment/thumbnailimage_lineextensions-feat-image-resized/ 2024-06-21T10:45:29+00:00 https://www.prescriptionanalytics.com/white-paper/understanding-prescription-drug-line-extensions-key-insights-on-ura-medicaid-rebates-and-340b-program-impact/attachment/thumbnailimage_lineextensions-blog-feat-image/ 2024-07-10T12:23:49+00:00 https://www.prescriptionanalytics.com/white-paper/why-are-my-medicaid-rebates-so-high/attachment/thumbnailimage_whymedicaidrebatessohigh-blog-feat-image-resized/ 2024-09-25T18:09:27+00:00 https://www.prescriptionanalytics.com/blog/cms-final-rule-what-pharma-manufacturers-need-to-know/attachment/thumbnailimage_cmsfinalrule-updated-blog-feat-image/ 2024-11-19T16:30:53+00:00 https://www.prescriptionanalytics.com/white-paper/baseline-amp-essential-guide-to-compliance-and-maximizing-profitability/attachment/thumbnailimage_baselineamp-wp-feat-image/ 2025-01-06T15:35:11+00:00 https://www.prescriptionanalytics.com/blog/emerging-u-s-tariff-policy-and-its-potential-impact-on-pharma-manufacturers/attachment/us-tariff-policy-feat-image/ 2025-07-30T16:34:58+00:00 https://www.prescriptionanalytics.com/blog/what-pharma-manufacturers-need-to-know-about-the-new-one-big-beautiful-bill-act-obbba/attachment/thumbnailimage_obbba-blog-feat-image-resized-2/ 2025-08-13T14:40:33+00:00 https://www.prescriptionanalytics.com/blog/2026-cms-proposed-rule-bfsf-clarifications-compliance-risks-for-pharma-manufacturers/attachment/thumbnailimage_2026cmsrule-blog-feat-image/ 2025-08-27T17:46:12+00:00 https://www.prescriptionanalytics.com/blog/2026-cms-proposed-rule-bfsf-clarifications-compliance-risks-for-pharma-manufacturers/attachment/thumbnailimage_2026cmsrule-blog-feat-image-2/ 2025-09-04T14:57:52+00:00 https://www.prescriptionanalytics.com/blog/pharma-executives-guide-trumprx-and-100-tariffs/attachment/thumbnailimage_pharmaexeguide-blog-feat-image/ 2025-10-14T11:18:53+00:00 https://www.prescriptionanalytics.com/blog/2026-cms-final-rule-expanded-asp-reporting-and-verification-requirements-for-manufacturers/attachment/thumbnailimage_2026cmsfinalrule-blog-feat-image/ 2025-11-19T13:21:54+00:00 https://www.prescriptionanalytics.com/blog/medicare-part-d-inflation-rebates-january-9-deadline-approaching/attachment/thumbnailimage_medicarepartdinflationrebate-resized/ 2026-01-06T15:53:39+00:00 https://www.prescriptionanalytics.com/blog/nevada-essential-drug-list-reporting-requirements-for-pharmaceutical-manufacturers/attachment/thumbnailimage_nevadasptr-blog-feat-image/ 2026-01-23T19:11:50+00:00 https://www.prescriptionanalytics.com/blog/pbm-reform-is-here-what-the-2026-appropriations-act-changes/attachment/thumbnailimage_pbmreform/ 2026-02-11T12:29:52+00:00 https://www.prescriptionanalytics.com/blog/pbm-reform-is-here-what-the-2026-appropriations-act-changes/attachment/thumbnailimage_pbmreform-blog-feat-image/ 2026-02-11T12:31:19+00:00 https://www.prescriptionanalytics.com/blog/what-the-12-digit-ndc-means-for-government-pricing-rebates-and-reporting/attachment/thumbnailimage_ndcformatchange/ 2026-03-17T19:34:58+00:00 https://www.prescriptionanalytics.com/blog/what-the-12-digit-ndc-means-for-government-pricing-rebates-and-reporting/attachment/thumbnailimage_ndcformatchange-scaled-e1773862858938-1-1/ 2026-03-18T20:13:06+00:00 https://www.prescriptionanalytics.com/regulatory-updates/cms-delays-new-q1-2026-asp-reporting-requirements/attachment/thumbnailimage_cmsdelaysq1aspreportingrequirements/ 2026-04-09T19:54:10+00:00 https://www.prescriptionanalytics.com/blog/va-federal-supply-schedule-contract-terms-may-extend-to-20-years/attachment/thumbnailimage_vacontractterms/ 2026-04-16T18:18:48+00:00 https://www.prescriptionanalytics.com/white-paper/medicaid-rebate-processing-trends-pharma-manufacturers-should-watch-in-2026/attachment/thumbnailimage_medicaidrebatetrends/ 2026-05-05T20:02:51+00:00 https://www.prescriptionanalytics.com/blog/va-labeler-code-enforcement/attachment/thumbnailimage_valabelercodeenforement/ 2026-09-10T15:36:55+00:00 https://www.prescriptionanalytics.com/blog/u-s-pharmaceutical-tariffs-expand-to-generic-drugs/attachment/thumbnailimage_pharmatariffs/ 2026-09-10T15:37:13+00:00 https://www.prescriptionanalytics.com/white-paper/are-you-considering-lowering-your-wac/attachment/thumbnailimage_considerloweringwac/ 2026-09-10T15:37:46+00:00 https://www.prescriptionanalytics.com/blog/dscsa-implementation-is-driving-new-state-licensing-requirements-for-drug-manufacturers/attachment/thumbnailimage_statelicensingblog/ 2026-09-21T15:19:16+00:00